U.S. Durable Medical Equipment Market Size, Share & Trends Analysis Report by Product, End Use, and Segment Forecasts, 2026-2033

1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Data Sources

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

3.1. Market Lineage Outlook
3.1.1. Ancillary Market Outlook
3.2. Regulatory Scenario
3.3. Reimbursement Scenario
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Increasing prevalence of chronic diseases
3.4.1.2. Rising geriatric population
3.4.1.3. Technological advancements and growing AI integration
3.4.1.4. Growing number of sports & road accidents coupled with the increasing number of injuries
3.4.1.5. Favorable government initiatives
3.4.2. Market Restraint Analysis
3.4.2.1. High costs associated with durable medical equipment
3.4.2.2. Lack of skilled professionals to handle this equipment
3.4.3. Market Opportunity Analysis
3.4.3.1. Growing demand for home healthcare services
3.4.3.2. Improving reimbursement for durable medical equipment
3.4.3.3. Rising production of medical equipment
3.4.3.4. Growing accessibility and availability of medical equipment
3.4.3.5. Increasing investments in medical
3.4.4. Market Challenge Analysis
3.4.4.1. Product recall
3.4.4.2. Growing accessibility and availability of medical equipment
3.5. DME Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Bargaining power of suppliers
3.5.1.2. Bargaining power of buyers
3.5.1.3. Threat of substitutes
3.5.1.4. Threat of new entrants
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political & Legal Landscape
3.5.2.2. Economic and Social Landscape
3.5.2.3. Technological landscape
3.5.3. COVID-19 Impact Analysis
3.5.3.1. Disrupted DME
3.5.3.2. Obstacles in DME

4.1. Segment Dashboard
4.2. DME Market: Product Movement Analysis & Market Share, 2025 & 2033
4.3. Personal Mobility Devices
4.3.1. Personal Mobility Devices Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2. Wheelchairs Market
4.3.2.1 Wheelchairs Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.2 Electric Wheelchairs Market
4.3.2.2.1 Electric Wheelchairs Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.2.3 Manual Wheelchairs Market
4.3.2.3.1 Manual Wheelchairs Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.3. Scooters Market
4.3.3.1 Scooters Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.4. Walker and Rollators Market
4.3.4.1 Walker and Rollators Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.5. Cranes and Crutches Market
4.3.5.1 Cranes and Crutches Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.6. Door Openers Market
4.3.6.1 Door Openers Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.3.7. Other Devices Market
4.3.7.1 Other Devices Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.4. Bathroom Safety Devices and Medical Furniture
4.4.1. Bathroom Safety Devices and Medical Furniture Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2. Commodes and Toilets Market
4.4.2.1 Commodes and Toilets Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3. Mattress & Bedding Devices Market
4.4.3.1 Mattress & Bedding Devices Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Monitoring and Therapeutic Devices
4.5.1. Monitoring and Therapeutic Devices Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.2. Blood Sugar Monitors Market
4.5.2.1 Blood Sugar Monitors Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.3. Continuous Passive Motion (CPM) Market
4.5.3.1 Commodes and Toilets Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.4. Infusion Pumps Market
4.5.4.1 Infusion Pumps Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.5. Nebulizers Market
4.5.5.1 Nebulizers Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.6. Infusion Pumps Market
4.5.6.1 Infusion Pumps Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.7. Oxygen Equipment Market
4.5.7.1 Oxygen Equipment Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.8. Continuous Positive Airway Pressure (CPAP) Market
4.5.8.1 Continuous Positive Airway Pressure (CPAP) Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.9. Suction pumps Market
4.5.9.1 Suction Pumps Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.10. Traction equipment Market
4.5.10.1 Traction Equipment Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.11. Others Market
4.5.11.1 Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.11.2 Insulin Pumps Market
4.5.11.2.1 Insulin Pumps Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.11.3 Ostomy Bags & Accessories Market
4.5.11.3.1 Ostomy Bags & Accessories Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.11.4 Wound Care Products Market
4.5.11.4.1 Wound Care Products Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.11.5 Cardiology Devices Market
4.5.11.5.1 Cardiology Devices Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.11.6 Vital Signs Monitor Market
4.5.11.6.1 Vital Signs Monitor Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.11.7 Respiratory Supplies Market
4.5.11.7.1 Respiratory Supplies Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.11.8 Urinary Supplies Market
4.5.11.8.1 Urinary Supplies Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.11.9 Diabetic Supplies Market
4.5.11.9.1 Diabetic Supplies Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.11.10 Incontinence Products Market
4.5.11.10.1 Incontinence Products Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.11.11 Orthopedic Braces & Support Market
4.5.11.11.1 Orthopedic Braces & Support Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.11.12 Muscle Stimulators Market
4.5.11.12.1 Muscle Stimulators Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.11.13 Others Market
4.5.11.13.1 Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

5.1. Segment Dashboard
5.2. DME Market: End Use Movement Analysis & Market Share, 2025 & 2033
5.3. Hospitals
5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.4. Specialty Clinics
5.4.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Ambulatory Surgical Centers
5.5.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.6. Diagnostic Centers
5.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.7. Home Healthcare
5.7.1. Home Healthcare Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.8. Others
5.8.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

6.1. Market Participant Categorization
6.2. Key Company Profiles
6.2.1. Invacare Corporation
6.2.1.1. Company Overview
6.2.1.2. Financial Performance
6.2.1.3. Product Benchmarking
6.2.1.4. Strategic Initiatives
6.2.2. Sunrise Medical
6.2.2.1. Company Overview
6.2.2.2. Financial Performance
6.2.2.3. Product Benchmarking
6.2.2.4. Strategic Initiatives
6.2.3. Arjo
6.2.3.1. Company Overview
6.2.3.2. Financial Performance
6.2.3.3. Product Benchmarking
6.2.3.4. Strategic Initiatives
6.2.4. Medline Industries, Inc.
6.2.4.1. Company Overview
6.2.4.2. Financial Performance
6.2.4.3. Product Benchmarking
6.2.4.4. Strategic Initiatives
6.2.5. GE HealthCare
6.2.5.1. Company Overview
6.2.5.2. Financial Performance
6.2.5.3. Product Benchmarking
6.2.5.4. Strategic Initiatives
6.2.6. GF Healthcare Products, Inc.
6.2.6.1. Company Overview
6.2.6.2. Financial Performance
6.2.6.3. Product Benchmarking
6.2.6.4. Strategic Initiatives
6.2.7. Carex Health Brands, Inc.
6.2.7.1. Company Overview
6.2.7.2. Financial Performance
6.2.7.3. Product Benchmarking
6.2.7.4. Strategic Initiatives
6.2.8. Cardinal Health
6.2.8.1. Company Overview
6.2.8.2. Financial Performance
6.2.8.3. Product Benchmarking
6.2.8.4. Strategic Initiatives
6.2.9. Drive DeVilbiss Healthcare
6.2.9.1. Company Overview
6.2.9.2. Financial Performance
6.2.9.3. Product Benchmarking
6.2.9.4. Strategic Initiatives
6.2.10. NOVA Medical Products
6.2.10.1. Company Overview
6.2.10.2. Financial Performance
6.2.10.3. Product Benchmarking
6.2.10.4. Strategic Initiatives
6.2.11. Kaye Products, Inc.
6.2.11.1. Company Overview
6.2.11.2. Financial Performance
6.2.11.3. Product Benchmarking
6.2.11.4. Strategic Initiatives
6.2.12. Karman Healthcare, Inc.
6.2.12.1. Company Overview
6.2.12.2. Financial Performance
6.2.12.3. Product Benchmarking
6.2.12.4. Strategic Initiatives
6.2.13. Numotion
6.2.13.1. Company Overview
6.2.13.2. Financial Performance
6.2.13.3. Product Benchmarking
6.2.13.4. Strategic Initiatives
6.2.14. Pride Mobility Products Corporation
6.2.14.1. Company Overview
6.2.14.2. Financial Performance
6.2.14.3. Product Benchmarking
6.2.14.4. Strategic Initiatives
6.2.15. Inogen, Inc.
6.2.15.1. Company Overview
6.2.15.2. Financial Performance
6.2.15.3. Product Benchmarking
6.2.15.4. Strategic Initiatives
6.2.16. CAIRE, Inc.
6.2.16.1. Company Overview
6.2.16.2. Financial Performance
6.2.16.3. Product Benchmarking
6.2.16.4. Strategic Initiatives
6.2.17. Portable Oxygen Solutions
6.2.17.1. Company Overview
6.2.17.2. Financial Performance
6.2.17.3. Product Benchmarking
6.2.17.4. Strategic Initiatives
6.2.18. Rhythm Healthcare, LLC
6.2.18.1. Company Overview
6.2.18.2. Financial Performance
6.2.18.3. Product Benchmarking
6.2.18.4. Strategic Initiatives
6.2.19. MedaCure Inc.
6.2.19.1. Company Overview
6.2.19.2. Financial Performance
6.2.19.3. Product Benchmarking
6.2.19.4. Strategic Initiatives
6.2.20. Compass Health Brands
6.2.20.1. Company Overview
6.2.20.2. Financial Performance
6.2.20.3. Product Benchmarking
6.2.20.4. Strategic Initiatives
6.2.21. Thermo Fisher Scientific, Inc.
6.2.21.1. Company Overview
6.2.21.2. Financial Performance
6.2.21.3. Product Benchmarking
6.2.21.4. Strategic Initiatives
6.2.22. Abbott
6.2.22.1. Company Overview
6.2.22.2. Financial Performance
6.2.22.3. Product Benchmarking
6.2.22.4. Strategic Initiatives
6.2.23. F. Hoffmann-La Roche Ltd.
6.2.23.1. Company Overview
6.2.23.2. Financial Performance
6.2.23.3. Product Benchmarking
6.2.23.4. Strategic Initiatives
6.2.24. Medtronic
6.2.24.1. Company Overview
6.2.24.2. Financial Performance
6.2.24.3. Product Benchmarking
6.2.24.4. Strategic Initiatives
6.2.25. Ascensia Diabetes Care Holdings AG
6.2.25.1. Company Overview
6.2.25.2. Financial Performance
6.2.25.3. Product Benchmarking
6.2.25.4. Strategic Initiatives
6.2.26. Byram Healthcare Centers, Inc.
6.2.26.1. Company Overview
6.2.26.2. Financial Performance
6.2.26.3. Product Benchmarking
6.2.26.4. Strategic Initiatives
6.2.27. Novo Nordisk
6.2.27.1. Company Overview
6.2.27.2. Financial Performance
6.2.27.3. Product Benchmarking
6.2.27.4. Strategic Initiatives
6.2.28. Insulet Corporation
6.2.28.1. Company Overview
6.2.28.2. Financial Performance
6.2.28.3. Product Benchmarking
6.2.28.4. Strategic Initiatives
6.2.29. Baxter
6.2.29.1. Company Overview
6.2.29.2. Financial Performance
6.2.29.3. Product Benchmarking
6.2.29.4. Strategic Initiatives
6.2.30. B. Braun SE
6.2.30.1. Company Overview
6.2.30.2. Financial Performance
6.2.30.3. Product Benchmarking
6.2.30.4. Strategic Initiatives
6.2.31. Micrel Medical Devices SA
6.2.31.1. Company Overview
6.2.31.2. Financial Performance
6.2.31.3. Product Benchmarking
6.2.31.4. Strategic Initiatives
6.2.32. Boston Scientific Corporation
6.2.32.1. Company Overview
6.2.32.2. Financial Performance
6.2.32.3. Product Benchmarking
6.2.32.4. Strategic Initiatives
6.2.33. Tandem Diabetes Care, Inc.
6.2.33.1. Company Overview
6.2.33.2. Financial Performance
6.2.33.3. Product Benchmarking
6.2.33.4. Strategic Initiatives
6.2.34. BD
6.2.34.1. Company Overview
6.2.34.2. Financial Performance
6.2.34.3. Product Benchmarking
6.2.34.4. Strategic Initiatives
6.2.35. Moog, Inc.
6.2.35.1. Company Overview
6.2.35.2. Financial Performance
6.2.35.3. Product Benchmarking
6.2.35.4. Strategic Initiatives
6.2.36. IRadimed Corporation
6.2.36.1. Company Overview
6.2.36.2. Financial Performance
6.2.36.3. Product Benchmarking
6.2.36.4. Strategic Initiatives
6.2.37. Koninklijke Philips N.V.
6.2.37.1. Company Overview
6.2.37.2. Financial Performance
6.2.37.3. Product Benchmarking
6.2.37.4. Strategic Initiatives
6.2.38. Siemens Medical Solutions USA, Inc.
6.2.38.1. Company Overview
6.2.38.2. Financial Performance
6.2.38.3. Product Benchmarking
6.2.38.4. Strategic Initiatives
6.2.39. Essity
6.2.39.1. Company Overview
6.2.39.2. Financial Performance
6.2.39.3. Product Benchmarking
6.2.39.4. Strategic Initiatives
6.2.40. Coloplast Corporation
6.2.40.1. Company Overview
6.2.40.2. Financial Performance
6.2.40.3. Product Benchmarking
6.2.40.4. Strategic Initiatives
6.2.41. Paul Hartmann AG
6.2.41.1. Company Overview
6.2.41.2. Financial Performance
6.2.41.3. Product Benchmarking
6.2.41.4. Strategic Initiatives
6.2.42. Hollister Incorporated
6.2.42.1. Company Overview
6.2.42.2. Financial Performance
6.2.42.3. Product Benchmarking
6.2.42.4. Strategic Initiatives
6.2.43. Convatec Group PLC
6.2.43.1. Company Overview
6.2.43.2. Financial Performance
6.2.43.3. Product Benchmarking
6.2.43.4. Strategic Initiatives
6.2.44. Enovis Corporation
6.2.44.1. Company Overview
6.2.44.2. Financial Performance
6.2.44.3. Product Benchmarking
6.2.44.4. Strategic Initiatives
6.2.45. Zynex, Inc.
6.2.45.1. Company Overview
6.2.45.2. Financial Performance
6.2.45.3. Product Benchmarking
6.2.45.4. Strategic Initiatives
6.2.46. ZOLL Medical Corporation
6.2.46.1. Company Overview
6.2.46.2. Financial Performance
6.2.46.3. Product Benchmarking
6.2.46.4. Strategic Initiatives
6.2.47. Össur
6.2.47.1. Company Overview
6.2.47.2. Financial Performance
6.2.47.3. Product Benchmarking
6.2.47.4. Strategic Initiatives
6.2.48. Breg, Inc.
6.2.48.1. Company Overview
6.2.48.2. Financial Performance
6.2.48.3. Product Benchmarking
6.2.48.4. Strategic Initiatives
6.2.49. Bauerfeind USA, Inc.
6.2.49.1. Company Overview
6.2.49.2. Financial Performance
6.2.49.3. Product Benchmarking
6.2.49.4. Strategic Initiatives
6.2.50. Biotronik
6.2.50.1. Company Overview
6.2.50.2. Financial Performance
6.2.50.3. Product Benchmarking
6.2.50.4. Strategic Initiatives
6.2.51. AliMed
6.2.51.1. Heat Company Overview
6.2.51.2. Financial Performance
6.2.51.3. Product Benchmarking
6.2.51.4. Strategic Initiatives
6.3. Map Analysis/ Company Market Position Analysis
6.4. Estimated Company Market Share Analysis, 2025
6.5. List of Other Key Market Players

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 US DME Market, by Product, 2021-2033 (USD Million)
Table 4 US DME Market, by End Use, 2021-2033 (USD Million)
Table 5 Participant’s Overview
Table 6 Financial Performance
Table 7 Service Benchmarking
Table 8 Strategic Initiatives

Figure 1 Information Procurement
Figure 2 Primary Research Pattern
Figure 3 Market Research Approaches
Figure 4 Value Chain-Based Sizing & Forecasting
Figure 5 Market Formulation & Validation
Figure 6 DME Market, Market Segmentation
Figure 7 Market Driver Relevance Analysis (Current & Future Impact)
Figure 8 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 9 Market Challenge Relevance Analysis (Current & Future Impact)
Figure 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Figure 11 Porter’s Five Forces Analysis
Figure 12 Country Marketplace: Key Takeaways
Figure 13 U.S. DME Market, 2021-2033 (USD Million)